T1	Participants 0 5	Japan
T2	Participants 184 249	atypical antipsychotic medications in patients with schizophrenia
T3	Participants 1086 1104	healthcare setting
T4	Participants 720 767	related to olanzapine and risperidone primarily
T5	Participants 1249 1292	aripiprazole, blonanserin, and paliperidone
T6	Participants 1297 1490	patients with schizophrenia aged 20 years or over who required antipsychotic medication or switching of the current medication to others for reasons such as lack of efficacy and intolerability.
T7	Participants 1722 1762	target number of subjects was set at 300
T8	Participants 2016 2058	under ordinary healthcare setting in Japan
